cabozantinib (S)-malate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 10 USDMF, 2 EU WC, 2 KDMF, 10 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

70 Drugs in Development

70 Drugs in Development

INTERMEDIATES

19 Intermediates Suppliers

19 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers, 8 FDA Orange Book, 11 Europe, 3 Canada, 12 Australia, 3 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 20MG BASE, CAPSULE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 8 DKSH, 2 Faran Shimi Pharmaceutical, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 21 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 35 Fillers, Diluents & Binders, 24 Disintegrants & Superdisintegrants, 20 Controlled & Modified Release, 19 Direct Compression, 19 Thickeners and Stabilizers, 15 Lubricants & Glidants, 12 Film Formers & Plasticizers, 12 Granulation, 9 Co-Processed Excipients, 9 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Topical, 3 Solubilizers, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 1 Parenteral